Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | BRAF |
Variant | L485S |
Impact List | missense |
Protein Effect | gain of function - predicted |
Gene Variant Descriptions | BRAF L485S lies within the protein kinase domain of the Braf protein (UniProt.org). L485S is predicted to confer a gain of function to Braf as indicated by increased kinase activity in an in vitro assay (PMID: 18413255), and has been demonstrated to confer Braf inhibitor resistance in cell culture (PMID: 31925410). |
Associated Drug Resistance | Y |
Category Variants Paths |
BRAF mutant BRAF act mut BRAF L485S BRAF mutant BRAF L485X BRAF L485S |
Transcript | NM_004333.6 |
gDNA | chr7:g.140778054A>G |
cDNA | c.1454T>C |
Protein | p.L485S |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001354609.1 | chr7:g.140778054A>G | c.1454T>C | p.L485S | RefSeq | GRCh38/hg38 |
NM_004333.5 | chr7:g.140778054A>G | c.1454T>C | p.L485S | RefSeq | GRCh38/hg38 |
NM_001378472.1 | chr7:g.140776996A>G | c.1454T>C | p.L485S | RefSeq | GRCh38/hg38 |
NM_004333.6 | chr7:g.140778054A>G | c.1454T>C | p.L485S | RefSeq | GRCh38/hg38 |
XM_005250045 | chr7:g.140778054A>G | c.1454T>C | p.L485S | RefSeq | GRCh38/hg38 |
NM_001378468.1 | chr7:g.140778054A>G | c.1454T>C | p.L485S | RefSeq | GRCh38/hg38 |
NM_001354609.2 | chr7:g.140778054A>G | c.1454T>C | p.L485S | RefSeq | GRCh38/hg38 |
NM_001378474.1 | chr7:g.140778054A>G | c.1454T>C | p.L485S | RefSeq | GRCh38/hg38 |
NM_001378473.1 | chr7:g.140776996A>G | c.1454T>C | p.L485S | RefSeq | GRCh38/hg38 |
XM_047420769.1 | chr7:g.140778054A>G | c.1454T>C | p.L485S | RefSeq | GRCh38/hg38 |
NM_004333 | chr7:g.140778054A>G | c.1454T>C | p.L485S | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|